Arab News, Saturday, Jan 28, 2023 | Rajab 6, 1444
Saudi Arabia signs deals to boost fight against diabetes
Saudi Arabia: Saudi Arabia has
signed two deals to improve the treatment and prevention of diabetes.
Memorandums of understanding were agreed with
German pharmaceutical firm Boehringer Ingelheim and the Danish healthcare
company Novo Nordisk at the Riyadh Global Medical Biotechnology Summit earlier
They aim to boost cooperation with the biotech and
pharmaceutical sector, localize manufacturing, raise awareness and establish
research centers in the Kingdom.
Under its deal, Boehringer Ingelheim will increase
the manufacture of medicine used to treat type 2 diabetes and diagnose rare
diseases in the Kingdom.
Novo Nordisk Saudi Arabia's deal with King
Abdullah University of Science and Technology will help develop awareness of
metabolic disorders, obesity and diabetes.
The agreements were negotiated by the Ministry of
Investment, and signed in the presence of Minister of Investment Khalid bin
Abdulaziz Al-Faleh. The health summit was organized by the Ministry of National
Guard Health Affairs.